Palvella Therapeutics PVLA
NASDAQ PVLA
$132.73 -5.20 (-3.77%)
At close: Oct 1, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) EV to FCF (2017 - 2024)

Updated

Palvella Therapeutics' EV to FCF came in at 0.17 for Q3 2024.

Analysis

Palvella Therapeutics (PVLA) EV to FCF (2017 - 2024) Analysis & Trends

For FY2017, Palvella Therapeutics' EV to FCF was 567.27.

  • The Q3 2024 figure represents the highest quarterly EV to FCF since Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Palvella Therapeutics 1.99 Bn 1.73 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 0.17
Jun 30, 2024 -0.85
Sep 30, 2018 17,921.08
Jun 30, 2018 427.07
Mar 31, 2018 551.19
Dec 31, 2017 567.27
Sep 30, 2017 442.50
Jun 30, 2017 2,308.15
Mar 31, 2017 1,024.83
API Access

Palvella Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=PVLA&period=max&api_key=YOUR_API_KEY